Breathing treatment with gemcitabine for lung cancer spread
Treatments studied
Part of Bones, joints & muscles, Cancer, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This early-stage trial studies an inhaled (aerosol) form of gemcitabine to treat solid tumors that have spread to the lungs. It aims to see whether this lung-focused treatment is safe and how well it might work when standard curative options are not available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor that has spread to your lungs (pulmonary metastases)
- There is no known curative treatment, or no proven treatment that improves survival with an acceptable quality of life
- You can follow the study plan and do safety checks (reporting symptoms, pulse oxygen checks, remote breathing tests, and bloodwork)
- Your blood and organ tests must meet minimum levels (counts, liver/kidney labs, and breathing function); you must not need oxygen at rest
- You must be between 12 and 49 years old, and your activity level should be reasonably good
- Any side effects from past cancer treatment should be mostly gone (except hair loss), and you should not have had radiation in the last 2 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two drugs—gemcitabine (a chemotherapy drug) and nab-sirolimus (a targeted therapy)—for people with advanced soft-tissue sarcoma or leiomyosarcoma, especially those whose tumors have a specific genetic change in the TSC2 or TSC1 genes. The goal is to see if this combination can shrink tumors or slow their growth.
This trial studies whether adding gemcitabine (a chemotherapy medicine) to standard radiation can better treat locally advanced cervical cancer. It also focuses on whether this treatment is safe and effective for people with reduced kidney function.
This trial tests gemcitabine chemotherapy in people with metastatic pancreatic cancer who cannot take FOLFIRINOX. It aims to see how well gemcitabine works based on a specific tumor marker called GemCore.
This trial tests an oral medication called GAS in people with pancreatic cancer that has spread to other parts of the body, who have not yet received any treatment for metastatic disease. The goal is to find the best dose and see how well it works.
This trial tests if adding leflunomide (a drug used for arthritis) to standard chemotherapy (gemcitabine) can help people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if the combination works better than gemcitabine alone.
This trial studies whether the herbal medicine HGXJT can improve outcomes and safety for people with non-small cell lung cancer that has spread to the bones. It is designed for a specific lung cancer type (EGFR and ALK wild type) and people who have not had certain immune treatments before.
Hear when a new Malignant Neoplasm of Bone and Articular Cartilage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.